Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126088752 | 12608875 | 2 | F | 201606 | 20160913 | 20160730 | 20160920 | EXP | ZA-AMGEN-ZAFSL2016096577 | AMGEN | 33.00 | YR | A | M | Y | 0.00000 | 20160920 | OT | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126088752 | 12608875 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Intravenous (not otherwise specified) | 60 MUG, QWK | D | 103951 | 60 | UG | INVESTIGATIONAL DOSAGE FORM | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126088752 | 12608875 | 1 | Nephrogenic anaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126088752 | 12608875 | HO |
| 126088752 | 12608875 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126088752 | 12608875 | Extra dose administered | |
| 126088752 | 12608875 | Hypotension | |
| 126088752 | 12608875 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126088752 | 12608875 | 1 | 201603 | 201609 | 0 |